Sanofi-Aventis Canada Inc. et al. v. Novopharm Ltd., [2009] F.T.R. Uned. 807 (FC)

JurisdictionFederal Jurisdiction (Canada)
JudgeSnider, J.
CourtFederal Court (Canada)
Subject MatterPRACTICE
Date06 November 2009
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
18 practice notes
  • Eurocopter v. Bell Helicopter Textron Canada Ltd., (2012) 415 F.T.R. 29 (FC)
    • Canada
    • Canada (Federal) Federal Court (Canada)
    • July 3, 2012
    ...307 F.T.R. 153 ; 2006 FC 1403 , refd to. [para. 20]. Sanofi-Aventis Canada Inc. et al. v. Novopharm Ltd., [2009] F.T.R. Uned. 807 ; 2009 FC 1139, refd to. [para. 22]. Adir v. Apotex Inc. - see Laboratoires Servier et al. v. Apotex Inc. et al. Laboratoires Servier et al. v. Apotex Inc. et ......
  • Allergan Inc. v. Sandoz Canada Inc., 2021 FC 186
    • Canada
    • Federal Court (Canada)
    • February 26, 2021
    ...level of costs in this Court is the mid-point of Column III in Tariff B: Rule 407; Sanofi-Aventis Canada Inc v Novopharm Limited, 2009 FC 1139 at para 4 [Sanofi-Novopharm FC], aff’d 2012 FCA 265; Apotex v Sanofi-Aventis, 2012 FC 318 at para 5 [Apotex v Sanofi-Aventis]; Dennis v Canad......
  • Hoffman-La Roche Ltd. v. Apotex Inc. et al., (2013) 444 F.T.R. 237 (FC)
    • Canada
    • Canada (Federal) Federal Court (Canada)
    • December 18, 2013
    ...of Column III" - See paragraphs 3 to 8. Cases Noticed: Sanofi-Aventis Canada Inc. et al. v. Novopharm Ltd., [2009] F.T.R. Uned. 807 ; 2009 FC 1139, refd to. [para. 3]. Novopharm Ltd. v. Eli Lilly & Co., [2010] F.T.R. Uned. 896 ; 2010 FC 1154 , refd to. [para. 3]. Merck & Co. et a......
  • Pharmascience Inc. v. Teva Canada, 2022 FCA 207
    • Canada
    • Court of Appeal (Canada)
    • December 1, 2022
    ...accept Pharmascience’s submission that Teva’s proposals could not be considered, citing Sanofi-Aventis Canada Inc. v. Novopharm Limited, 2009 FC 1139, aff’d 2012 FCA 265 [Sanofi/Novopharm]. Given “Teva’s proposals to settle”, the Federal Court said that an order that each party bear its own......
  • Request a trial to view additional results
18 cases
  • Eurocopter v. Bell Helicopter Textron Canada Ltd., (2012) 415 F.T.R. 29 (FC)
    • Canada
    • Canada (Federal) Federal Court (Canada)
    • July 3, 2012
    ...307 F.T.R. 153 ; 2006 FC 1403 , refd to. [para. 20]. Sanofi-Aventis Canada Inc. et al. v. Novopharm Ltd., [2009] F.T.R. Uned. 807 ; 2009 FC 1139, refd to. [para. 22]. Adir v. Apotex Inc. - see Laboratoires Servier et al. v. Apotex Inc. et al. Laboratoires Servier et al. v. Apotex Inc. et ......
  • Allergan Inc. v. Sandoz Canada Inc., 2021 FC 186
    • Canada
    • Federal Court (Canada)
    • February 26, 2021
    ...level of costs in this Court is the mid-point of Column III in Tariff B: Rule 407; Sanofi-Aventis Canada Inc v Novopharm Limited, 2009 FC 1139 at para 4 [Sanofi-Novopharm FC], aff’d 2012 FCA 265; Apotex v Sanofi-Aventis, 2012 FC 318 at para 5 [Apotex v Sanofi-Aventis]; Dennis v Canad......
  • Hoffman-La Roche Ltd. v. Apotex Inc. et al., (2013) 444 F.T.R. 237 (FC)
    • Canada
    • Canada (Federal) Federal Court (Canada)
    • December 18, 2013
    ...of Column III" - See paragraphs 3 to 8. Cases Noticed: Sanofi-Aventis Canada Inc. et al. v. Novopharm Ltd., [2009] F.T.R. Uned. 807 ; 2009 FC 1139, refd to. [para. 3]. Novopharm Ltd. v. Eli Lilly & Co., [2010] F.T.R. Uned. 896 ; 2010 FC 1154 , refd to. [para. 3]. Merck & Co. et a......
  • Pharmascience Inc. v. Teva Canada, 2022 FCA 207
    • Canada
    • Court of Appeal (Canada)
    • December 1, 2022
    ...accept Pharmascience’s submission that Teva’s proposals could not be considered, citing Sanofi-Aventis Canada Inc. v. Novopharm Limited, 2009 FC 1139, aff’d 2012 FCA 265 [Sanofi/Novopharm]. Given “Teva’s proposals to settle”, the Federal Court said that an order that each party bear its own......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT